2-{5-[3-methyl-5-oxo-1-(4-sulfamoyl-phenyl)-1,5-dihydro-pyrazol-(4Z)-ylidenemethyl]-furan-2-yl}-benzoic acid

ID: ALA378729

PubChem CID: 5730311

Max Phase: Preclinical

Molecular Formula: C22H17N3O6S

Molecular Weight: 451.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=NN(c2ccc(S(N)(=O)=O)cc2)C(=O)/C1=C\c1ccc(-c2ccccc2C(=O)O)o1

Standard InChI:  InChI=1S/C22H17N3O6S/c1-13-19(21(26)25(24-13)14-6-9-16(10-7-14)32(23,29)30)12-15-8-11-20(31-15)17-4-2-3-5-18(17)22(27)28/h2-12H,1H3,(H,27,28)(H2,23,29,30)/b19-12-

Standard InChI Key:  MFAUPOYGLDVFKL-UNOMPAQXSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    9.6188   -4.1400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4060   -4.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8182   -5.5527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6337   -5.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0343   -4.8609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8134   -4.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0329   -3.4265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8579   -3.4283    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6219   -2.7111    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4067   -3.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7461   -2.6675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1344   -2.1126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4181   -2.5243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5897   -3.3323    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6648   -2.1880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9969   -2.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2159   -2.4171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7296   -3.0846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2156   -3.7528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0005   -3.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9621   -1.6321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6696   -3.9785    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9619   -4.5371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1538   -4.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8998   -5.4928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4530   -6.1061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2633   -5.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5135   -5.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2002   -6.8914    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9833   -7.6833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4095   -6.6560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9897   -7.1306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 19 20  1  0
 20 16  1  0
  4  5  2  0
 17 21  1  0
  5  1  1  0
 20 22  2  0
  1  6  2  0
  6  2  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
  6 10  1  0
  1  7  1  0
 13 15  1  0
  2  3  2  0
 23 24  2  0
 15 16  2  0
 24 25  1  0
 17 18  2  0
 25 26  2  0
  7  8  2  0
 26 27  1  0
  3  4  1  0
 27 28  2  0
 28 23  1  0
 19 23  1  0
  7  9  1  0
 26 29  1  0
 11 12  1  0
 29 30  1  0
 16 17  1  0
 29 31  2  0
 18 19  1  0
 29 32  2  0
M  END

Associated Targets(Human)

HEY (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 451.46Molecular Weight (Monoisotopic): 451.0838AlogP: 3.10#Rotatable Bonds: 5
Polar Surface Area: 143.27Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.33CX Basic pKa: CX LogP: 2.47CX LogD: -0.95
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -1.45

References

1. Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X, Neamati N..  (2006)  Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.,  49  (15): [PMID:16854058] [10.1021/jm051296s]

Source